Table 3 Univariate and multivariate analysis of No.10/11LN metastasis for 152 advanced proximal gastric cancer patients who underwent curative gastrectomy with splenectomy or pancreatectomy

91 (77.1%)

27 (22.9%)

17 (50.0%)

17 (55.0%)

0.002

1.162

0.374–3.616

0.795

84 (89.4%)

10 (10.6%)

24 (41.4%)

34 (58.6%)

< 0.001

6.780

2.316–19.846

< 0.001

97 (72.9%)

36 (27.1%)

11 (57.9%)

8 (42.1%)

0.176

94 (74.6%)

32 (25.4%)

14 (53.8%)

12 (46.2%)

0.034

2.615

0.735–9.306

0.138

93 (78.8%)

25 (21.2%)

15 (44.1%)

19 (55.9%)

< 0.001

2.483

0.811–7.602

0.111

99 (75.0%)

33 (25.0%)

9 (45.0%)

11 (55.0%)

0.006

1.869

0.469–7.454

0.376

106 (75.2%)

35 (24.8%)

2 (18.2%)

9 (81.8%)

< 0.001

3.338

1.249–3.595

0.202

100 (71.4%)

40 (28.6%)

8 (66.7%)

4 (33.3%)

0.727

27 (71.1%)

11 (28.9%)

64 (72.7%)

24 (27.3%)

17 (65.4%)

9 (34.6%)

0.769

28 (82.4%)

6 (17.6%)

68 (73.1%)

25 (26.9%)

1.117

0.318–3.919

0.863

12 (48.0%)

13 (52.0%)

0.013

2.126

0.417–10.846

0.365

29 (80.6%)

7 (19.4%)

79 (68.1%)

37 (31.9%)

0.150

55 (80.9%)

13 (19.1%)

53 (63.1%)

31 (36.9%)

0.016

1.313

0.465–3.707

0.607

75 (82.4%)

16 (17.6%)

33 (54.1%)

28 (45.9%)

< 0.001

2.963

1.112–7.897

0.030